 |
recombinant human cerebral dopamine neurotrophic factor |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2016-06-08 00:00:00 |
| Sponsor | Herantis Pharma Plc;4 Viikinkaari;Helsinki |
| |
recombinant human cerebral dopamine neurotrophic factor |
|---|---|
| Trade Name | |
| Orphan Indication | Amyotrophic lateral sclerosis |
| USA Market Approval | USA |
| USA Designation Date | 2016-06-08 00:00:00 |
| Sponsor | Herantis Pharma Plc;4 Viikinkaari;Helsinki |